GHK-Cu is a copper-binding tripeptide widely studied for its involvement in collagen synthesis, antioxidant activity, and gene expression related to tissue remodeling
Cross-trial scans favor tirzepatide: semaglutide measured about 62:38 fat-to-lean loss versus roughly 75:25 for tirzepatide. The scan overstates muscle loss, however, because lean mass includes water and organs
Side effects, such as mild stomach upset, can make an appearance
The foreign object causes coughing, trouble breathing and sometimes choking
The companys stock collapsed from a $17 IPO price (September 2020) to under $1
Overall, these findings raise concerns about GLP-1 RA use in patients with reduced LVEF